A.T.P.C. Gomes et al. / Tetrahedron 67 (2011) 7336e7342
7341
nebulizer gas and argon was used as the collision gas. Samples were
introduced into the mass spectrometer using a flow rate of 10 L/
(CHCl3): lmax (log
3
m
nm; HRMS (ESI) m/z calcd for C58H42N5O3Zn [MþH]þ 920.2579,
min, the needle voltage was set at 3000 V, with the ion source at
80 ꢀC and needle temperature at 150 ꢀC. Cone voltage was 30 V.
Collision-induced decomposition mass spectra (MS/MS) were ac-
quired by selecting the desired precursor ion with the quadrupole
section of the mass spectrometer and using collision energy of
25e40 eV. The UVevis spectra were recorded on an UV-2501 PC
Shimatzu spectrophotometer using CHCl3 as solvent. Flash chro-
matography was carried out using silica gel (230e400 mesh).
Preparative thin-layer chromatography was carried out on
20ꢂ20 cm glass plates coated with silica gel (1 mm thick). Analytical
TLC was carried out on precoated plastic sheets with silica gel
(Merck 60, 0.2 mm thick). Porphyrin 3, 2-(4,4,5,5-tetramethyl-1,3
,2-dioxaborolan-2-yl)-5,10,15,20-tetraphenylporphyrinatozinc(II),
was prepared according to the literature.27
found 920.2559.
4.2.3. 2-[3-Ethoxycarbonyl-1-(2,3,5-tri-O-benzoyl-
yl)-4-oxo-1,4-dihydroquinolin-6-yl]-5,10,15,20-tetraphenylporphyr-
inatozinc(II), 4c. Yield: 51%; 1H NMR (300 MHz, CDCl3)
8.94 and 8,83
(AB, 2H, J¼4.6 Hz, H-7 and H-8), 8.96 (s, 1H, H-3), 8.92 (s, 2H, H-12
and H-13), 8.86 (s,1H, H-20), 8.84 and 8.74 (AB, 2H, J¼4.7 Hz, H-17 and
H-18), 8.57 (d, 1H, J¼2.0 Hz, H-50), 8.26e8.16 (m, 6H, Ho-Ph-5,10,15),
8.11 (dd, 2H, J¼1.4 and 7.8 Hz, H-2000), 7.99e8.03 (m, 2H, Ho-Ph-20),
7.97 (dd, 2H, J¼1.4 and 7.8 Hz, H-2000), 7.77e7.74 (m, 12H, Hm,p-Ph-
5,10,15,20), 7.56 (tt, 2H, J¼1.4 and 6.1 Hz, H-4000), 7.43e7.34 (m, 9H, 6ꢂ
H-3000, H-4000, H-70 and H-80), 7.15e6.90 (m, 2H, H-2000), 6.39 (d, 1H,
J¼5.1 Hz, H-100), 6.07 (t, 1H, J¼5.1 Hz, H-200), 5.93 (t, 1H, J¼5.1 Hz, H-
300), 4.96e4.79 (m, 3H, H-400 and H-500), 4.33e4.14 (m, 1H,
CO2CH2CH3), 1.32 (t, 1H, J¼7.1 Hz, CO2CH2CH3) ppm. 13C NMR
4.2. Coupling reactions of porphyrin 3 with bromoquinolones
(75 MHz, CDCl3) d
174.3 (C-40), 166.0 (CO2CH2CH3), 165.1 (C]O Bz),
2aed. General procedure
165.0 (C]O Bz), 164.6 (C]O Bz), 150.9, 150.5, 150.4, 150.33, 150.30,
150.2, 147.5 (C-20), 146.1, 142.6, 141.1, 135.7, 135.5 (C-2), 134.4 (C-70),
134.1,133.8,133.6,132.6,132.19,132.12,131.9 (C-20),131.5,129.9,129.8,
129.7, 129.2, 128.9 (C-50), 128.7, 128.6, 128.5, 128.4, 128.3, 128.1, 127.5,
127.4, 126.9, 126.5, 121.9, 121.4, 121.0, 120.8, 113.5 (C-80), 91.2 (H-100),
80.3 (H-400 or H-500), 70.5, 70.4, 63.2 (H-400 or H-500), 62.8, 60.9, 29.7,
29.5 (CO2CH2CH3), 14.29 (CO2CH2CH3) ppm. UVevis (CHCl3): lmax
Porphyrin
(33.5 mol), Cs2CO3 (6.5 mg, 19.9
9.6 mol), DMF (0.5 mL) and toluene (1 mL) were brought together
3
(10.0 mg, 12.4
m
mol), bromoquinolones 2aed
m
mmol), Pd(PPh3)4 (11.0 mg,
m
in a 25 mL Schlenk tube. The solvent was degassed by repeated
sonication for 0.5e1 min under reduced pressure. The reaction
mixture was stirred for 16 h at 80 ꢀC, the mixture was quenched
with aq. NaCl and extracted with CH2Cl2. The organic layer was
washed with water, dried (Na2SO4) and concentrated. The residue
was purified by column chromatography using a mixture of tolu-
ene/ethyl acetate as the eluent.
(log
)¼428 (5.35), 558 (4.25), 598 (3.81), 673 (2.89) nm; HRMS (ESI)
4.2.4. 2-[3-Ethoxycarbonyl-1-(2,3,5-tri-O-benzoyl-
1-yl)-4-oxo-1,4-dihydroquinolin-7-yl]-5,10,15,20-tetraphenylporphy-
rinatozinc(II), 4d. Yield: 50%; 1H NMR (300 MHz, DMSO-d6):
8.92
(s, 1H, H-20), 8.81e8.76 (m, 4H,
-H), 8.69 (d, 1H, J¼4.6 Hz, H-17 or
H-18), 8.63e8.58 (m, 2H, -H), 8.23e8.08 (m, 8H, Ho-Ph-5,10,15),
b-D-ribofuranos-
d
4.2.1. 2-(3-Ethoxycarbonyl-1-ethyl-4-oxo-1,4-dihydroquinolin-6-yl)-
b
5,10,15,20-tetraphenylporphyrinatozinc(II), 4a. Yield: 89%; 1H NMR
b
(500 MHz, CDCl3)
d
8.95 and 8.93 (AB, 2H, J¼4.7 Hz, H-7 and H-8),
7.98e7.95 (m, 2H, H-2000), 7.81e7.79 (m, 9H, Hm,p-Ph-5,10,15,20),
7.72e7.70 (m, 2H, H-2000), 7.66e7.55 (m, 9H, 4ꢂ H-3000, 3ꢂ H-4000, H-50
and H-80), 7.40 (t, 2H, J¼7.7 Hz, H3000), 7.09 (t, 2H, J¼7.5 Hz, Hm-Ph-
20), 6.97e6.92 (m, 1H, H-200), 6.77 (br s, 2H, H-2000), 6.54e6.49 (m,
1H, H-100), 6.20e6.06 (m, 1H, Hp-Ph-20), 5.84e5.93 (m, 1H, H-300),
5.01e4.97 (m,1H, H-400), 4.82e4.79 (m, 3H, H-500), 4.19e4.05 (m, 2H,
CO2CH2CH3), 1.22 (t, 3H, J¼7.0 Hz, CO2CH2CH3) ppm. 13C RMN
(125 MHz, DMSO): 172.5 (C-40),165.5 (CO2CH2CH3),164.6 (C]O Bz),
164.2 (C]O Bz), 163.5 (C]O Bz), 149.5, 146.4 (C-20), 142.9, 142.5,
139.3, 134.1, 133.6, 131.6, 129.5, 129.3, 128.9, 128.7, 128.5, 128.1,
127.5, 126.7, 126.5, 120.1, 119.2, 111.5, 88.7, 80.8, 75.1, 70.6, 64.0, 59.8,
8.93 (s, 2H, H-12 and H13), 8.91 (s, 1H, H-3), 8.85 and 8.76 (AB, 2H,
J¼4.7 Hz, H-17 and H-18), 8.70 (d, 1H, J¼2.1 Hz, H-50), 8.52 (s, 1H, H-
20), 8.26e8.17 (m, 6H, Ho-Ph-5,10,15), 8.02e7.86 (m, 2H, Ho-Ph-20),
7.81e7.69 (m, 9H, Hm,p-Ph-5,10,15), 7.50 (dd, 1H, J¼2.1 and 8.6 Hz,
H-70), 7.11e7.06 (m, 2H, Hm-Ph-20), 7.49e7.48 (m, 1H, Hp-Ph-20),
7.08 (d, 1H, J¼8.6 Hz, H-80), 4.42 (q, 2H, J¼7.2 Hz, CO2CH2CH3),
4.28e4.27 (m, 2H, NCH2CH3),1.61 (t, 3H, J¼7.2 Hz, NCH2CH3),1.45 (t,
3H, J¼7.2 Hz, CO2CH2CH3) ppm. 13C NMR (75 MHz, CDCl3)
d 174.2
(C-40), 166.3 (CO2CH2CH3), 151.0, 150.5, 150.4, 150.3, 150.2, 148.3 (C-
20), 147.6, 145.2, 142.65, 142.65, 141.4, 137.0, 136.3, 135.7,134.8 (C-70),
134.4, 134.3, 132.5, 132.2, 132.1, 132.0, 131.5, 131.4, 128.6, 128.38 (C-
50), 128.34, 128.2, 127.5, 127.4, 126.6, 126.8, 126.6, 121.8, 121.7, 121.4,
121.0, 120.8, 114.3 (C-80), 110.9, 60.9 (NCH2CH3), 48.9 (CO2CH2CH3),
14.7 (NCH2CH3), 14.5 (CO2CH2CH3) ppm. UVevis (CHCl3): lmax
13.9 (CO2CH2CH3). UVevis (CHCl3): lmax (log
(4.07), 600 (3.63), 666 (3.18) nm; HRMS (ESI) m/z calcd for
3
C82H58N5O10Zn [MþH]þ 1336.3470, found 1336.3468.
(log
)¼423 (5.47), 511 (3.37), 550 (4.10), 587 (3.32) nm; HRMS (ESI)
4.3. Deprotection and demetallation of porphyrin/quinolone
conjugates 4aed. General procedure
4.2.2. 2-(3-Ethoxycarbonyl-1-ethyl-4-oxo-1,4-dihydroquinolin-7-
A
solution of the porphyrin/quinolone conjugate 4aed
mol) in 1.78 M methanolic potassium hydroxide solution
yl)-5,10,15,20-tetraphenylporphyrinatozinc(II), 4b. Yield: 82%; 1H
(7.5
m
NMR (500 MHz, CDCl3)
d
8.96 and 8.93 (AB, 2H, J¼4.6 Hz, H-7 and
(2.5 mL) and THF/Py (0.5 mL/50 m
L) was stirred at 80 ꢀC for 1 h
H-8), 8.94e8.93 (m, 3H, H-3, H-12 and H-13), 8.87 and 8.78 (AB, 2H,
J¼4.6 Hz, H-17 and H-18), 8.48 (s, 1H, H-20), 8.24e8.20 (m, 7H, Ho-
Ph-5,10,15 and H-50), 7.91e7.84 (m, 2H, Ho-Ph-20), 7.77e7.74 (m,
9H, Hm,p-Ph-5,10,15), 7.57 (d, 1H, J¼8.7 Hz, H-60), 7.29 (s, 1H, H-80),
7.17e6.94 (m, 3H, Hm,p-Ph-20), 4.41 (q, 2H, 7.2 Hz, CO2CH2CH3),
4.26e4.05 (m, 2H, NCH2CH3),1.45 (t, 3H, J¼7.1 Hz, NCH2CH3),1.40 (t,
(compounds 4a,b) or 24 h (compounds 4c,d) in a sealed tube.28 The
resulting solution was neutralized with aqueous solution of citric
acid. The mixture was extracted with chloroform and then the or-
ganic phase was washed with water and dried over Na2SO4. The
solvent was evaporated under reduced pressure to dryness. The
residue was dissolved in CHCl3 (1 mL) and neat TFA (0.1 mL) was
added. This mixture was stirred in the dark at room temperature for
2 min. Chloroform and water were then added and the mixture was
neutralized with aqueous sodium carbonate. The mixture was
extracted with chloroform, the organic phase was washed with
water, dried over Na2SO4 and the solvent was evaporated under
reduced pressure to dryness. Pure porphyrin/quinolone conjugates
3H, J¼7.1 Hz, CO2CH2CH3) ppm. 13C NMR (75 MHz, CDCl3)
d 174.3
(C-40), 166.3 (CO2CH2CH3), 151.0, 150.7, 150.57, 150.53, 150.4, 150.3,
150.2,148.4 (C-20), 147.2,145.1, 142.6, 142.5, 141.3,137.4,135.2,134.4,
134.3, 132.6, 132.3, 132.2, 131.7, 127.54, 127.49, 127.5, 127.2, 126.8,
126.6, 122.1, 121.7, 121.6, 121.2, 120.9, 117.2, 110.7, 60.9 (NCH2CH3),
48.4 (CO2CH2CH3), 14.6 (NCH2CH3), 14.4 (CO2CH2CH3) ppm. UVevis